» Articles » PMID: 23166529

Association Study Between Folate Pathway Gene Single Nucleotide Polymorphisms and Gastric Cancer in Koreans

Overview
Journal Genomics Inform
Publisher Biomed Central
Specialty Biology
Date 2012 Nov 21
PMID 23166529
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Gastric cancer is ranked as the most common cancer in Koreans. A recent molecular biological study about the folate pathway gene revealed the correlation with a couple of cancer types. In the folate pathway, several genes are involved, including methylenetetrahydrofolate reductase (MTHFR), methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR), and methyltetrahydrofolate-homocysteine methyltransferase (MTR). The MTHFR gene has been reported several times for the correlation with gastric cancer risk. However, the association of the MTRR or MTR gene has not been reported to date. In this study, we investigated the association between the single nucleotide polymorphisms (SNPs) of the MTHFR, MTRR, and MTR genes and the risk of gastric cancer in Koreans. To identify the genetic association with gastric cancer, we selected 17 SNPs sites in folate pathway-associated genes of MTHFR, MTR, and MTRR and tested in 1,261 gastric cancer patients and 375 healthy controls. By genotype analysis, estimating odds ratios and 95% confidence intervals (CI), rs1801394 in the MTRR gene showed increased risk for gastric cacner, with statistical significance both in the codominant model (odds ratio [OR], 1.39; 95% CI, 1.04 to 1.85) and dominant model (OR, 1.34; 95% CI, 1.02 to 1.75). Especially, in the obese group (body mass index ≥ 25 kg/m(2)), the codominant (OR, 9.08; 95% CI, 1.01 to 94.59) and recessive model (OR, 3.72; 95% CI, 0.92 to 16.59) showed dramatically increased risk (p < 0.05). In conclusion, rs1801394 in the MTRR gene is associated with gastric cancer risk, and its functional significance need to be validated.

Citing Articles

A genome-wide and candidate gene association study of preterm birth in Korean pregnant women.

Hur Y, Yoo J, You Y, Park S, Kim S, Lee G PLoS One. 2023; 18(11):e0294948.

PMID: 38019868 PMC: 10686439. DOI: 10.1371/journal.pone.0294948.


Targeting Homocysteine and Hydrogen Sulfide Balance as Future Therapeutics in Cancer Treatment.

Majumder A Antioxidants (Basel). 2023; 12(8).

PMID: 37627515 PMC: 10451792. DOI: 10.3390/antiox12081520.


SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling.

Wang W, Wang M, Du T, Hou Z, You S, Zhang S Int J Mol Sci. 2023; 24(8).

PMID: 37108312 PMC: 10138966. DOI: 10.3390/ijms24087150.


MTRR rs1532268 polymorphism and gastric cancer risk: evidence from a meta-analysis.

Zhong G, Luo X, Li J, Liao Y, Gui G, Sheng J J Int Med Res. 2022; 50(5):3000605221097486.

PMID: 35579185 PMC: 9127855. DOI: 10.1177/03000605221097486.


Association of MTHFR C677T polymorphism with severity and localization of chronic atrophic gastritis patients without Helicobacter pylori infection: a case control study.

Kong S, Ye F, Dang Y, Hua Y, Zhang G BMC Cancer. 2020; 20(1):725.

PMID: 32758174 PMC: 7405366. DOI: 10.1186/s12885-020-07208-2.


References
1.
Hubner R, Houlston R . Folate and colorectal cancer prevention. Br J Cancer. 2008; 100(2):233-9. PMC: 2634716. DOI: 10.1038/sj.bjc.6604823. View

2.
Sun L, Sun Y, Wang B, Cao H, Yu C . Methylenetetrahydrofolate reductase polymorphisms and susceptibility to gastric cancer in Chinese populations: a meta-analysis. Eur J Cancer Prev. 2008; 17(5):446-52. DOI: 10.1097/CEJ.0b013e328305a140. View

3.
Ohnami S, Sato Y, Yoshimura K, Ohnami S, Sakamoto H, Aoki K . His595Tyr polymorphism in the methionine synthase reductase (MTRR) gene is associated with pancreatic cancer risk. Gastroenterology. 2008; 135(2):477-88. DOI: 10.1053/j.gastro.2008.04.016. View

4.
Bosco P, Gueant-Rodriguez R, Anello G, Barone C, Namour F, Caraci F . Methionine synthase (MTR) 2756 (A --> G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am J Med Genet A. 2003; 121A(3):219-24. DOI: 10.1002/ajmg.a.20234. View

5.
Beyer K, Lao J, Latorre P, Riutort N, Matute B, Fernandez-Figueras M . Methionine synthase polymorphism is a risk factor for Alzheimer disease. Neuroreport. 2003; 14(10):1391-4. DOI: 10.1097/01.wnr.0000073683.00308.0e. View